IVD News and Research

RSS
VENTANA ALK (D5F3) CDx Assay receives FDA approval

VENTANA ALK (D5F3) CDx Assay receives FDA approval

Bio-Techne to acquire 100% ownership of Cliniqa

Bio-Techne to acquire 100% ownership of Cliniqa

Ventana, Halozyme partner to develop companion diagnostic assay for cancer treatment

Ventana, Halozyme partner to develop companion diagnostic assay for cancer treatment

First new treatment authorised in a decade for advanced cervical cancer patients in the UK

First new treatment authorised in a decade for advanced cervical cancer patients in the UK

Cepheid, FIND announce receipt of CE-IVD status for Xpert HIV-1 Qual test

Cepheid, FIND announce receipt of CE-IVD status for Xpert HIV-1 Qual test

Mobidiag announces CE-IVD marking and launching of Amplidiag C. difficile+027 test

Mobidiag announces CE-IVD marking and launching of Amplidiag C. difficile+027 test

Frost & Sullivan forecasts growth of global healthcare market

Frost & Sullivan forecasts growth of global healthcare market

Healthcare reform changes boost glucose testing in states with healthcare exchanges

Healthcare reform changes boost glucose testing in states with healthcare exchanges

MTI Expo 2015 to focus on engineering requirements in the medical technology sector

MTI Expo 2015 to focus on engineering requirements in the medical technology sector

Kalorama Information: Budding market for digital PCR reached 175 million in 2014

Kalorama Information: Budding market for digital PCR reached 175 million in 2014

Tissue and cell diagnostics market reaches $7.7 billion in 2014

Tissue and cell diagnostics market reaches $7.7 billion in 2014

Biocartis to develop Rapid Ebola Virus Triage Test

Biocartis to develop Rapid Ebola Virus Triage Test

Sophia Genetics obtains CE-IVD marking for BRCA1/2 testing solution

Sophia Genetics obtains CE-IVD marking for BRCA1/2 testing solution

QIAGEN's circulating tumor DNA test CE-IVD marked to assess genomic mutation NSCLC patients

QIAGEN's circulating tumor DNA test CE-IVD marked to assess genomic mutation NSCLC patients

DiaCarta raises $8 million in Series A financing from BVCF

DiaCarta raises $8 million in Series A financing from BVCF

Proteomics market expected to experience continual growth

Proteomics market expected to experience continual growth

FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test

FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test

Sophia Genetics earns ISO 13485 and ISO 27001 certification for safe data handling and security

Sophia Genetics earns ISO 13485 and ISO 27001 certification for safe data handling and security

FDA takes immediate steps to help reduce risk of spreading unsuspected uterine cancer

FDA takes immediate steps to help reduce risk of spreading unsuspected uterine cancer

Synovasure PJI Alpha Defensin Test now available for sale in Europe

Synovasure PJI Alpha Defensin Test now available for sale in Europe